DeepMed Research

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Gender Differences in Prevalence of Undiagnosed Diabetes in ACS

Completed

Conditions: Diabetes
Pre-diabetes

First Posted Date: 2008-01-09

Last Posted Date: 2023-08-30

Lead Sponsor: Yale University

Target Recruit Count: 103

Registration Number: NCT00589459

Locations: 🇺🇸
Yale Center for Clinical Investigation, New Haven, Connecticut, United States
🇺🇸
Bridgeport Hospital, Bridgeport, Connecticut, United States

Message Framing for Telephone Quitline Callers

Phase 1

Completed

Conditions: Nicotine Dependence
Smoking

Interventions: Behavioral: Gain-Framed counseling & Gain-framed materials
Behavioral: Standard care counseling + standard materials

First Posted Date: 2008-01-09

Last Posted Date: 2021-08-26

Lead Sponsor: Yale University

Target Recruit Count: 2032

Registration Number: NCT00589277

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD

Not Applicable

Completed

Conditions: Fatty Liver
Insulin Resistance

Interventions: Other: Low-fat diet
Other: Traditional diet

First Posted Date: 2008-01-03

Last Posted Date: 2014-06-17

Lead Sponsor: Yale University

Target Recruit Count: 4

Registration Number: NCT00585299

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues

Phase 1

Completed

Conditions: Cocaine Dependence

Interventions: Drug: Placebo
Drug: Progesterone

First Posted Date: 2008-01-03

Last Posted Date: 2014-02-12

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT00585520

Locations: 🇺🇸
Yale University School of Medicine: Research Program on Stress, Addiction, and Psychopathology, New Haven, Connecticut, United States

Memantine Treatment Study of Pathological Gambling

Phase 2

Completed

Conditions: Pathological Gambling

Interventions: Drug: Memantine Hydrochloride

First Posted Date: 2008-01-03

Last Posted Date: 2013-04-08

Lead Sponsor: Yale University

Target Recruit Count: 29

Registration Number: NCT00585169

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
🇺🇸
University of Minnesota Medical Center, Fairview, Minneapolis, Minnesota, United States

Vascular Effects of Sertraline in Heart Failure

Terminated

Conditions: Heart Failure
Depression

Interventions: Drug: sertraline

First Posted Date: 2008-01-03

Last Posted Date: 2009-07-23

Lead Sponsor: Yale University

Target Recruit Count: 4

Registration Number: NCT00585455

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse

Phase 1

Completed

Conditions: Alcohol Dependence

Interventions: Drug: Prazosin Tablet
Drug: Placebo Tablet

First Posted Date: 2008-01-03

Last Posted Date: 2020-07-27

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT00585780

Locations: 🇺🇸
Yale University School of Medicine: Yale Stress Center, New Haven, Connecticut, United States

Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse

Phase 1

Completed

Conditions: Cocaine Dependent
Alcohol Dependent

Interventions: Drug: Placebo
Drug: Guanfacine

First Posted Date: 2008-01-03

Last Posted Date: 2016-11-30

Lead Sponsor: Yale University

Target Recruit Count: 75

Registration Number: NCT00585754

Locations: 🇺🇸
Yale University School of Medicine: Yale Stress Center, New Haven, Connecticut, United States

Modafinil, Sleep, and Cognition in Cocaine Dependence

Not Applicable

Completed

Conditions: Cocaine Dependence
Substance-induced Sleep Disorder
Substance-induced Cognitive Disorder

Interventions: Drug: Placebo
Drug: Modafinil

First Posted Date: 2007-12-28

Last Posted Date: 2012-09-14

Lead Sponsor: Yale University

Target Recruit Count: 44

Registration Number: NCT00582491

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Clinical Efficacy of Disulfiram in LAAM-Maintained Cocaine Abusers

Not Applicable

Completed

Conditions: Cocaine-Related Disorder
Opiate Dependence

Interventions: Drug: Placebo
Drug: Disulfiram

First Posted Date: 2007-12-27

Last Posted Date: 2020-03-31

Lead Sponsor: Yale University

Target Recruit Count: 126

Registration Number: NCT00580827

Locations: 🇺🇸
West Haven VA, West Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy